Keystone eSymposia Logo

Joint meeting with NeuroImmune Interactions in Health and Disease

Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics

June 7-9, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change



Joint Meetings

Your registration provides you with access to both the “Neurodegenerative Diseases: Genes, Mechanisms and Therapeutics” and “NeuroImmune Interactions in Health and Disease” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!

  View Joint Meeting On Demand Content



Reset

Advanced Filters
09:00am - 10:10am EDT - June 7, 2021
Eric J. Huang, MD, PhD, Co-Chair, University of California, San Francisco; Beth Stevens, PhD, Co-Chair, Boston Children's Hospital, Harvard Medical School
Track: [Joint Session] Welcoming Remarks and Keynote Address

Monday
09:00am - 09:40am EDT - June 7, 2021
Akiko Iwasaki, PhD, Yale University School of Medicine
Track: [Joint Session] Welcoming Remarks and Keynote Address

Monday
09:40am - 10:10am EDT - June 7, 2021
Christopher K. Glass, MD, PhD, University of California, San Diego
Track: [Joint Session] Welcoming Remarks and Keynote Address

10:10am - 01:00pm EDT - June 7, 2021
Joseph W. Lewcock, PhD, Co-Chair, Denali Therapeutics; Kate Monroe, PhD, Co-Chair, Denali Therapeutics
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
10:10am - 10:35am EDT - June 7, 2021 | Room: V300 - Ian
Holly Kordasiewicz, PhD, Ionis Pharmaceuticals
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
10:35am - 11:00am EDT - June 7, 2021 | Room: V300 - Ian
Joseph W. Lewcock, PhD, Denali Therapeutics
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
11:00am - 11:25am EDT - June 7, 2021 | Room: V300 - Ian
Kate Monroe, PhD, Denali Therapeutics
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
11:50am - 12:15pm EDT - June 7, 2021
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
12:15pm - 12:30pm EDT - June 7, 2021
Raz Dvir Szternfeld, MS, Weizmann Institute of Science
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
12:30pm - 12:45pm EDT - June 7, 2021
Christiane D. Wrann, PhD, Massachusetts General Hospital
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

Monday
12:45pm - 01:00pm EDT - June 7, 2021
Elise Marsan, PhD, University of California, San Francisco
Track: [Joint Session] Disease Mechanisms and Therapeutic Targets

01:00pm - 02:30pm EDT - June 7, 2021
Joseph W. Lewcock, PhD, Co-Chair, Denali Therapeutics; Charlotte J. Sumner, MD, Co-Chair, Johns Hopkins School of Medicine
Track: From Therapeutic Targets to Clinic

Monday
01:00pm - 01:25pm EDT - June 7, 2021
Charlotte J. Sumner, MD, Johns Hopkins School of Medicine
Track: From Therapeutic Targets to Clinic

Monday
01:25pm - 01:50pm EDT - June 7, 2021
Beverly L. Davidson, PhD, Children’s Hospital of Philadelphia and University of Pennsylvania
Track: From Therapeutic Targets to Clinic

Monday
01:50pm - 02:15pm EDT - June 7, 2021
Lorenz Studer, MD, Memorial Sloan Kettering Cancer Center
Track: From Therapeutic Targets to Clinic

Monday
02:15pm - 02:30pm EDT - June 7, 2021
Priyanka Narayan, PhD, National Institute of Health
Track: From Therapeutic Targets to Clinic

09:00am - 10:20am EDT - June 8, 2021
Valina L. Dawson, PhD, Co-Chair, Johns Hopkins University School of Medicine; Alison Goate, PhD, Co-Chair, Icahn School of Medicine at Mount Sinai
Track: Genetic Contributions to Neurodegeneration

Tuesday
09:00am - 09:25am EDT - June 8, 2021 | Room: V300 - Ian
Alison Goate, PhD, Icahn School of Medicine at Mount Sinai
Track: Genetic Contributions to Neurodegeneration

Tuesday
09:25am - 09:50am EDT - June 8, 2021 | Room: V300 - Ian
Jennifer Yokoyama, PhD, University of California, San Francisco
Track: Genetic Contributions to Neurodegeneration

Tuesday
09:50am - 10:05am EDT - June 8, 2021 | Room: V300 - Ian
Martine Therrien, PhD, Broad Institute
Track: Genetic Contributions to Neurodegeneration

Tuesday
10:05am - 10:20am EDT - June 8, 2021 | Room: V300 - Ian
Andy Po-Yi Tsai, MS, Indiana University School of Medicine
Track: Genetic Contributions to Neurodegeneration

10:20am - 11:30am EDT - June 8, 2021
Alison Goate, PhD, Co-Chair, Icahn School of Medicine at Mount Sinai; Valina L. Dawson, PhD, Co-Chair, Johns Hopkins University School of Medicine
Track: Cellular Pathways Targeted by Neurodegeneration

Tuesday
10:20am - 10:45am EDT - June 8, 2021
Valina L. Dawson, PhD, Johns Hopkins University School of Medicine
Track: Cellular Pathways Targeted by Neurodegeneration

Tuesday
10:45am - 11:00am EDT - June 8, 2021
Christian Hoffmann, PhD, German Center for Neurodegenerative Diseases - DZNE
Track: Cellular Pathways Targeted by Neurodegeneration

Tuesday
11:00am - 11:15am EDT - June 8, 2021
Kathryn M. Hixson, PhD, UNC Chapel Hill
Track: Cellular Pathways Targeted by Neurodegeneration

Tuesday
11:15am - 11:30am EDT - June 8, 2021
Noah Johnson, PhD, University of Colorado Anschutz Medical Campus
Track: Cellular Pathways Targeted by Neurodegeneration

12:05pm - 02:25pm EDT - June 8, 2021
Michael T. Heneka, MD, Co-Chair, German Center for Neurodegenerative Diseases; Mathew M. Blurton-Jones, PhD, Co-Chair, University of California, Irvine
Track: Glial Contributions to Neurodegeneration

Tuesday
12:05pm - 12:25pm EDT - June 8, 2021 | Room: V300 - Ian
Marco Prinz, MD, University of Freiburg
Track: Glial Contributions to Neurodegeneration

Tuesday
12:25pm - 12:50pm EDT - June 8, 2021 | Room: V300 - Ian
Ádám Dénes, PhD, Hungarian Academy of Sciences
Track: Glial Contributions to Neurodegeneration

Tuesday
12:50pm - 01:15pm EDT - June 8, 2021 | Room: V300 - Ian
Anne Schaefer, MD, PhD, Mount Sinai School of Medicine
Track: Glial Contributions to Neurodegeneration

Tuesday
01:15pm - 01:40pm EDT - June 8, 2021 | Room: V300 - Ian
Michael T. Heneka, MD, German Center for Neurodegenerative Diseases
Track: Glial Contributions to Neurodegeneration

Tuesday
01:55pm - 02:10pm EDT - June 8, 2021 | Room: V300 - Ian
Patrick W. Sheehan, BS, Washington University in St. Louis
Track: Glial Contributions to Neurodegeneration

Tuesday
02:10pm - 02:25pm EDT - June 8, 2021 | Room: V300 - Ian
Sabina Tahirovic, PhD, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. - DZNE
Track: Glial Contributions to Neurodegeneration

Tuesday
03:30pm - 04:30pm EDT - June 8, 2021
Swapnika Ramu, PhD, Cell Press; Gabriel A. Gasque, PhD, PLOS (Public Library of Science); Sophie Morgan, PhD, Nature Communications; Tim Spencer, PhD, Journal of Cell Biology (JCB)
Track: Keystone Symposia Roundtables

09:00am - 10:45am EDT - June 9, 2021
Eric J. Huang, MD, PhD, Co-Chair, University of California, San Francisco; Virginia M. Y. Lee, PhD, Co-Chair, University of Pennsylvania School of Medicine
Track: Phase Separation, Protein Aggregation and Transmission

Wednesday
09:00am - 09:25am EDT - June 9, 2021 | Room: V300 - Ian
J. Paul Taylor, MD, PhD, St. Jude Children's Research Hospital
Track: Phase Separation, Protein Aggregation and Transmission

Wednesday
09:25am - 09:50am EDT - June 9, 2021 | Room: V300 - Ian
Sjors Scheres, PhD, MRC Laboratory of Molecular Biology
Track: Phase Separation, Protein Aggregation and Transmission

Wednesday
09:50am - 10:15am EDT - June 9, 2021 | Room: V300 - Ian
Virginia M. Y. Lee, PhD, University of Pennsylvania School of Medicine
Track: Phase Separation, Protein Aggregation and Transmission

Wednesday
10:15am - 10:30am EDT - June 9, 2021 | Room: V300 - Ian
Alyssa Coyne, PhD, Johns Hopkins University School of Medicine
Track: Phase Separation, Protein Aggregation and Transmission

Wednesday
10:30am - 10:45am EDT - June 9, 2021 | Room: V300 - Ian
Roberta Romano, PhD, University of Salento
Track: Phase Separation, Protein Aggregation and Transmission

10:45am - 01:00pm EDT - June 9, 2021
Li-Huei Tsai, PhD, Co-Chair, Massachusetts Institute of Technology; Richard M. Ransohoff, MD, Co-Chair, Harvard Medical School
Track: Epigenetics and Transcriptomics of the Aging Brain

Wednesday
10:45am - 11:10am EDT - June 9, 2021
Li-Huei Tsai, PhD, Massachusetts Institute of Technology
Track: Epigenetics and Transcriptomics of the Aging Brain

Wednesday
11:10am - 11:35am EDT - June 9, 2021
Philip L. De Jager, MD, PhD, Columbia University Medical Center
Track: Epigenetics and Transcriptomics of the Aging Brain

Wednesday
12:05pm - 12:30pm EDT - June 9, 2021
Anne Brunet, PhD, Stanford University
Track: Epigenetics and Transcriptomics of the Aging Brain

Wednesday
12:30pm - 12:45pm EDT - June 9, 2021
Carlos Cruchaga, PhD, Washington University School of Medicine
Track: Epigenetics and Transcriptomics of the Aging Brain

Wednesday
12:45pm - 01:00pm EDT - June 9, 2021
Hyo Won Ahn, MS, National Institute of Child Health and Human Development
Track: Epigenetics and Transcriptomics of the Aging Brain

01:00pm - 02:40pm EDT - June 9, 2021
Li-Huei Tsai, PhD, Co-Chair, Massachusetts Institute of Technology; Mathew M. Blurton-Jones, PhD, Co-Chair, University of California, Irvine
Track: Modeling Neuro-Immune Interactions in Neurodegeneration

Wednesday
01:00pm - 01:25pm EDT - June 9, 2021 | Room: V300 - Ian
Fred H. Gage, PhD, The Salk Institute for Biological Studies
Track: Modeling Neuro-Immune Interactions in Neurodegeneration

Wednesday
01:25pm - 01:50pm EDT - June 9, 2021 | Room: V300 - Ian
Track: Modeling Neuro-Immune Interactions in Neurodegeneration

Wednesday
01:50pm - 02:15pm EDT - June 9, 2021 | Room: V300 - Ian
Mathew M. Blurton-Jones, PhD, University of California, Irvine
Track: Modeling Neuro-Immune Interactions in Neurodegeneration

Wednesday
02:15pm - 02:30pm EDT - June 9, 2021 | Room: V300 - Ian
Emmy Li, BS, University of California, San Francisco
Track: Modeling Neuro-Immune Interactions in Neurodegeneration

Wednesday
02:30pm - 02:40pm EDT - June 9, 2021 | Room: V300 - Ian
Track: Modeling Neuro-Immune Interactions in Neurodegeneration